Hatzis-Schoch Brent

CIK 00016370542 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001637054

Recent Transactions

50 trades

Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2026-01-21+250,000→ 250,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2025-01-30+175,000→ 175,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-01-30+75,000→ 83,400 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2024-02-14+200,000→ 200,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2023-02-13+200,000→ 200,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2022-02-15+90,000→ 90,000 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-05-12$27.90/sh−2,566→ 8,751 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-05-12$28.20/sh−351→ 8,400 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-05-12$3.20/sh+4,078→ 12,478 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-05-12$26.11/sh−1,161→ 11,317 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-05-12−4,078→ 160,474 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-04-12−179,915→ 164,552 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-04-12$25.00/sh−4,078→ 8,400 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-04-12$3.20/sh+4,078→ 12,478 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-03-12$26.36/sh−4,078→ 8,400 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-03-12$3.20/sh+4,078→ 12,478 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-03-12−4,078→ 168,630 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-02-17+75,000→ 75,000 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-02-12$3.20/sh+4,078→ 12,478 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-02-12−4,078→ 172,708 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-02-12$27.66/sh−307→ 8,400 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-02-12$27.19/sh−3,771→ 8,707 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$10.86/sh+7,500→ 19,978 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$29.92/sh−2,048→ 17,930 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$34.13/sh−100→ 15,911 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-01-12−7,500→ 71,251 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$32.50/sh−103→ 16,011 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$36.00/sh−7,511→ 8,400 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-01-12−4,078→ 176,786 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$31.91/sh−147→ 16,114 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$3.20/sh+4,078→ 12,478 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-01-12$30.50/sh−1,669→ 16,261 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-12-28$3.20/sh+5,400→ 8,400 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-12-28−5,400→ 180,864 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-12-14−4,078→ 186,264 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-12-14$34.95/sh−4,078→ 3,000 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-12-14$3.20/sh+4,078→ 7,078 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-11-12$34.24/sh−2,261→ 3,250 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-11-12−4,078→ 190,342 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-11-12$35.01/sh−250→ 3,000 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-11-12$33.46/sh−1,567→ 5,511 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-11-12$3.20/sh+4,078→ 7,078 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-10-12−4,078→ 194,420 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-10-12$32.61/sh−3,783→ 3,295 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-10-12$33.75/sh−295→ 3,000 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-10-12$3.20/sh+4,078→ 7,078 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-14$32.55/sh−207→ 3,000 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-14$31.42/sh−1,186→ 3,207 total
Sale
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-14$30.76/sh−2,685→ 4,393 total
Exercise/Conversion
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-14$3.20/sh+4,078→ 7,078 total

Companies

Recent Filings

Address

C/O BLACK DIAMOND THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov